Home/ Supplements/ Electrolytes/ T-Bomb 3xtreme

T-Bomb 3xtreme

product on market Tablet or Pill MHP Maximum Human Performance Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 60% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains magnesium, zinc, and copper, which are essential minerals that support hormonal health and metabolic function. While these ingredients have moderate evidence for supporting testosterone levels in deficient individuals, the overall evidence coverage for this specific blend is limited. The product maintains a high safety profile.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for T-Bomb 3xtreme
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
56
Servings
Other Combinations
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

15 mg (4% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
25 mg (227% DV)
2.3× RDA — within safe limits 263 studies (A:6, B:134)
2 mg (222% DV)
2.2× RDA — within safe limits 37 studies (A:0, B:11)
Clinical Strength, 5-Phase Testoterone Boosting and Estrogen Control Complex
1084 mg
Testosterone Signaling Amplification Blend
625 mg

Other Ingredients

Dicalcium Phosphate Microcrystalline Cellulose Polyvinyl Alcohol Titanium Dioxide Polyethylene Glycol Talc Croscarmellose Sodium Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: As a dietary supplement, take 3 tablets in the morning and 3 tablets in the evening with 8 fl. oz. of water. You may take before, during or after a meal - whichever is preferred.

Formulation Notes

Clinically tested testosterone formula 32% greater bioactive Free testosterone without increasing estrogen Five-phase hormone optimizing complex

Metadata

Product Details

DSLD Entry Date2024-09-25
Product TypeOther Combinations
FormTablet or Pill
DSLD ID316285
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.